BeStock  
Stocks › Biotechnology › IMTX

Immatics IMTX

US equityMarket cap rank #3162Biotechnology
$7.45 −$0.05 (-0.67%)
Pre-market · Oct 8, 9:10 am ET · After hours $7.88 +5.77%
Open$7.44
Prev close$7.50
Day range$7.31 – $7.70
Volume926.2K
Market cap$1.11B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026 · reported in EUR

Revenue€9.14M+93.0% YoY
Operating profit-€67.20M-26.5% YoY
Net profit-€62.49M+11.2% YoY
Diluted EPS-€0.46+20.7% YoY
Free cash flow-€61.33M-51.0% YoY
Operating cash flow-€60.46M

Revenue, last 8 quarters

€50.6MSep '24€56.3MDec '24€18.6MMar '25€4.7MJun '25€5.2MSep '25€19.8MDec '25€7.6MMar '26€9.1MJun '26

Net profit, last 8 quarters

€-5.3MSep '24€40.8MDec '24€-39.9MMar '25€-70.3MJun '25€-50.5MSep '25€-35.7MDec '25€-57.8MMar '26€-62.5MJun '26

Diluted EPS by quarter

-0.08Sep '240.39Dec '24-0.33Mar '25-0.58Jun '25-0.42Sep '25-0.29Dec '25-0.43Mar '26-0.46Jun '26

Free cash flow by quarter

€-36.5MSep '24€-60.2MDec '24€-37.3MMar '25€-40.6MJun '25€-45.8MSep '25€-59.7MDec '25€-42.8MMar '26€-61.3MJun '26

Annual revenue

€31.3MFY20€34.8MFY21€172.8MFY22€54.0MFY23€155.8MFY24€48.3MFY25

Profitability & balance sheet

Operating margin-543.8%
Net margin-495.3%
Return on equity-47.8%
Return on assets-39.2%
Return on invested capital-49.1%
Current ratio7.54
Liabilities / assets17.7%
Cash & investments€393.35M
Total debt€11.94M
Net cash (debt)€381.41M

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Income statement

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Total Revenue as Reported €9.14M €7.61M €48.27M €19.76M €5.19M
Total Operating Revenue €9.14M €7.61M €48.27M €19.76M €5.19M
Operating Expense €76.35M €73.68M €230.28M €58.64M €59.82M
Selling and Admin Expenses €13.94M €14.51M €51.18M €13.66M €12.67M
-General & Admin Expense €13.94M €14.51M €51.18M €13.66M €12.67M
Research & Development €62.41M €59.19M €183.83M €49.64M €47.18M
Operating Profit -€67.20M -€66.06M -€182.02M -€38.88M -€54.63M
Net Non-Operating Interest Income (Expense) €3.08M €3.37M €16.23M €3.33M €3.68M
Non-Operating Interest Income €3.29M €3.58M €17.18M €3.55M €3.91M
Non-Operating Interest Expense €203,000.00 €212,000.00 €946,000.00 €222,000.00 €231,000.00
Other Income (Expense) €1.35M €4.93M -€32.65M -€11,000.00 €282,000.00
Gain on Sale of Security €1.35M €4.93M -€32.65M -€11,000.00 €282,000.00
Pretax Profit -€62.77M -€57.76M -€198.44M -€35.56M -€50.67M
Tax -€274,000.00 €52,000.00 -€1.99M €134,000.00 -€127,000.00
Net Profit -€62.49M -€57.81M -€196.45M -€35.70M -€50.55M
Profit from Continuing Operations -€62.49M -€57.81M -€196.45M -€35.70M -€50.55M
Net Income to Parent Company -€62.49M -€57.81M -€196.45M -€35.70M -€50.55M
Other Preferred Stock Dividends €0.00 – – – €0.00
Net Income to Common Stockholders -€62.49M -€57.81M -€196.45M -€35.70M -€50.55M
Basic EPS -€0.46 -€0.43 -€1.61 -€0.29 -€0.42
Diluted EPS -€0.46 -€0.43 -€1.61 -€0.29 -€0.42
Other Operating Expenses – -€24,000.00 -€4.73M -€4.66M -€29,000.00

Balance sheet

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Total Assets €485.74M €543.26M €562.34M €562.34M €518.56M
Total Current Assets €429.19M €484.84M €504.01M €504.01M €458.02M
Cash and Cash Equivalents & Short-Term Investments €393.35M €453.57M €469.34M €469.34M €430.84M
-Cash and Cash Equivalents €232.46M €301.33M €345.92M €345.92M €334.92M
-Short Term Investments €160.89M €152.24M €123.42M €123.42M €95.92M
Receivables €6.66M €4.82M €6.88M €6.88M €4.30M
-Accounts Receivable €5.63M €4.15M €6.10M €6.10M €3.20M
-Taxes Receivable €1.04M €662,000.00 €782,000.00 €782,000.00 €1.11M
Prepaid Assets €10.59M €8.86M €12.92M €12.92M €13.70M
Other Current Assets €18.59M €17.59M €14.87M €14.87M €9.18M
Total Non-Current Assets €56.54M €58.43M €58.33M €58.33M €60.53M
Net PPE €51.70M €53.44M €54.90M €54.90M €58.15M
-Gross PPE €51.70M €53.44M €84.66M €84.66M €58.15M
Non-Current Prepaid Assets €2.58M €2.71M €1.08M €1.08M €89,000.00
Goodwill and Other Intangible Assets €1.56M €1.58M €1.58M €1.58M €1.56M
Other Non-Current Assets €700,000.00 €698,000.00 €769,000.00 €769,000.00 €731,000.00
Total Liabilities €86.11M €87.46M €78.24M €78.24M €101.88M
Total Current Liabilities €56.95M €55.25M €43.01M €43.01M €62.26M
Payables €7.11M €8.85M €2.69M €2.69M €3.49M
-Accounts Payable €6.24M €8.05M €340,000.00 €340,000.00 €2.80M
-Total Tax Payable €865,000.00 €797,000.00 €2.35M €2.35M €682,000.00
Current Accrued Expenses €26.91M €23.53M €18.49M €18.49M €19.73M
Short-Term Debt and Capital Lease Obligation €2.67M €2.61M €2.76M €2.76M €2.88M
-Current Capital Lease Obligation €2.67M €2.61M €2.76M €2.76M €2.88M
Current Deferred Liabilities €9.57M €13.22M €15.82M €15.82M €25.56M
Other Current Liabilities €1.99M €2.35M €1.55M €1.55M €2.13M
Total Non-Current Liabilities €29.16M €32.21M €35.23M €35.23M €39.62M
Long Term Debt and Capital Lease Obligation €11.94M €12.47M €12.88M €12.88M €13.50M
-Long Term Capital Lease Obligation €11.94M €12.47M €12.88M €12.88M €13.50M
Non-Current Deferred Liabilities €17.22M €19.74M €22.35M €22.35M €26.12M
Total Equity €399.63M €455.80M €484.10M €484.10M €416.68M
Stockholders' Equity €399.63M €455.80M €484.10M €484.10M €416.68M
Capital Stock €1.37M €1.37M €1.34M €1.34M €1.22M
-Common Stock €1.37M €1.37M €1.34M €1.34M €1.22M
Additional Paid-In Capital €1.31B €1.30B €1.28B €1.28B €1.17B
Retained Earnings -€906.29M -€843.80M -€785.99M -€785.99M -€750.29M
Gains/Losses Not Affecting Retained Earnings -€5.53M -€6.72M -€8.59M -€8.59M -€8.11M
-Accumulated Depreciation – – -€29.76M -€29.76M –
-Other Intangible Assets – – €1.58M €1.58M –

Cash flow

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Operating Cash Flow -€60.46M -€42.04M -€176.63M -€58.67M -€44.70M
Net cash flow from continuing operations -€60.46M -€42.04M -€176.63M -€58.67M -€44.70M
Net Income from Continuing Operations -€62.49M -€57.81M -€196.45M -€33.58M -€52.67M
Gain/Loss from Continuing Operations -€1.36M -€5.42M €33.15M €814,000.00 -€213,000.00
Depreciation & Depletion & Amortization €3.00M €2.78M €12.40M €3.17M €3.07M
Deferred Tax -€274,000.00 €52,000.00 -€1.99M – –
Other Non-Cash Items -€3.08M -€3.37M -€16.23M -€3.33M -€3.68M
Change in Working Capital -€4.28M €13.50M -€43.97M -€30.04M -€2.01M
-Change in Receivables -€1.34M €1.95M -€242,000.00 -€2.90M -€1.24M
-Change in Other Current Assets -€2.42M €1.16M -€6.11M -€4.55M -€1.28M
-Change In Other Working Capital -€524,000.00 €10.40M -€37.62M -€22.59M €506,000.00
Net cash flow from investing -€8.15M -€28.08M €204.79M -€28.92M €122.65M
Net Cash Flow from Continuing Investing Activities -€8.15M -€28.08M €204.79M -€28.92M €122.65M
Net PPE Purchase and Sale -€868,000.00 -€739,000.00 -€6.56M -€1.02M -€1.09M
Net Intangibles Purchase and Sale €0.00 €0.00 -€247,000.00 -€57,000.00 €0.00
Net Investment Purchase and Sale -€7.29M -€27.35M €211.59M -€27.85M €123.74M
Financing Cash Flow -€666,000.00 €20.97M €97.35M €99.55M -€734,000.00
Net Cash Flow from Continuing Financing Activities -€666,000.00 €20.97M €97.35M €99.55M -€734,000.00
Net Issuance Payments Of Debt -€723,000.00 -€760,000.00 -€2.96M -€748,000.00 -€738,000.00
Net Common Stock Issuance €57,000.00 €22.27M €107.31M €107.30M €4,000.00
Net Other Financing Charges €0.00 -€542,000.00 -€7.00M – –
Ending Cash Balance €232.46M €301.33M €345.92M €345.92M €334.92M
Net Change in Cash -€69.28M -€49.16M €125.51M €11.97M €77.22M
Beginning Cash Balance €301.33M €345.92M €236.75M €334.92M €256.64M
Effect of Exchange Rate Changes €407,000.00 €4.57M -€16.34M -€970,000.00 €1.07M
Free Cash Flow -€61.33M -€42.81M -€183.43M -€59.69M -€45.79M

Discussion

No comments yet — be the first to weigh in on IMTX.

Leave a comment

Scroll to Top